A
AGN
ARGENICA
0.120
+0.010+9.09%Closed16:10 05/29 AEST
OPEN/PREV CLOSE0.115/0.110
TODAY RANGE0.110-0.125
VOL156.78K
MARKET CAP15.41M
52 WEEK RANGE0.110-0.850
AVG VOL (3M)188.21K
% TURNOVER0.12%
TURNOVER18.48K
P/E (TTM)-1.5748
% RANGE13.64%
EPS(TTM)-0.0762
P/E(FORWARD)--
P/B4.478
BVPS0.027
DIVIDEND--
P/S30.00
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP10.58M
SHARES OUTSTANDING128.46M
NEXT EARNINGS--
FREE FLOAT88.17M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
ASX·05/13 23:16
Clinical Advisory Committee Established to Advance Phase 2b
ASX·04/29 00:00
Argenica Therapeutics Ltd Prelim Q3
ASX·04/15 23:17
Investor Presentation - Ignite Conference
ASX·03/25 21:15
Presentations at European Stroke Organisation Conference
ASX·03/16 21:22
Argenica Receives $3.97m R&D Tax Incentive Cash Rebate
ASX·02/10 21:18
Half Yearly Report and Accounts
ASX·02/04 21:25
Investor Presentation - Euroz Hartleys Healthcare Conference
ASX·02/01 22:02
Successful Applicaton for EMA Paediatric Waiver
ASX·01/27 21:17
Quarterly Activities/Appendix 4C Cash Flow Report
ASX·01/02 05:54
Final Director's Interest Notice
ASX·12/28/2025 21:27
Non-Executive Chair Resignation
ASX·12/10/2025 22:14
AI Analysis Reveals Efficacy In Severe Stroke Patients
ASX·12/03/2025 21:18
Positive TNK Study Results Fulfil Key FDA Requirement
Same Industry
Name/Symbol
Change%
Price
No data yet, let's see others